Contraceptive Market: Global Industry Information, Trends and Forecast to 2022 by Brisk Insights
Brisk Insights has announced the addition of "Contraceptive Market: Global Industry Information, Trends and Forecast to 2022" Market Research Report to their Database.
Nottingham, United Kingdom, June 09, 2016 --(PR.com)-- As stated in a recently published information by Brisk Insights Global Contraceptive Market is expected to grow at the CAGR of 4.3% during 2015-2022 and it estimated to be $32.9 billion by 2022. The global contraceptive market is segmented on the basis of products, and geography. The information on global contraceptive market forecast 2015-2022 provides detailed overview and predictive analysis of the market.
The global contraceptive market is expected to grow well during the forecasted period on the back of factors such as growing prevalence of sexually transmitted infections (STIs), such as HIV. The presence of high unmet contraceptive needs coupled with the implementation of favorable government policies is expected to significantly contribute towards the growth of the contraceptives industry. However various ethical and social issues restrict the use of contraceptives in some countries in Middle-East region. These are some factors restraining the market growth.
The application market for contraceptives is segmented by products and geography. The products segment is further divided into drugs, such as topical contraceptives, injectable, and oral contraceptive pills. Out of all the segments, contraceptive devices holds the largest market share with 62%, presently. Male and female condoms, vaginal implants, subdermal implants, diaphragms, sponges and IUDs are key devices accounted for the significant share of the contraceptives market in terms of revenue. This is because of the increase in the awareness level about sexually transmitted disease (STD) and the efficiency of condoms to prevent the infections, including HIV.
The key players in the global contraceptive market include Teva Pharmaceutical Industries, The Female Health Company, Reckitt Benckiser Plc, Pfizer Inc., Church & Dwight, Mayer Laboratories, Cooper Surgical, Actavis plc, and Merck & Co.etc. The market has high level of competition and remains the same during the forecasted period with constant pressure on players to launch new products.
Browse Full Information with Toc : http://www.briskinsights.com/report/contraceptive-market
The global contraceptive market is expected to grow well during the forecasted period on the back of factors such as growing prevalence of sexually transmitted infections (STIs), such as HIV. The presence of high unmet contraceptive needs coupled with the implementation of favorable government policies is expected to significantly contribute towards the growth of the contraceptives industry. However various ethical and social issues restrict the use of contraceptives in some countries in Middle-East region. These are some factors restraining the market growth.
The application market for contraceptives is segmented by products and geography. The products segment is further divided into drugs, such as topical contraceptives, injectable, and oral contraceptive pills. Out of all the segments, contraceptive devices holds the largest market share with 62%, presently. Male and female condoms, vaginal implants, subdermal implants, diaphragms, sponges and IUDs are key devices accounted for the significant share of the contraceptives market in terms of revenue. This is because of the increase in the awareness level about sexually transmitted disease (STD) and the efficiency of condoms to prevent the infections, including HIV.
The key players in the global contraceptive market include Teva Pharmaceutical Industries, The Female Health Company, Reckitt Benckiser Plc, Pfizer Inc., Church & Dwight, Mayer Laboratories, Cooper Surgical, Actavis plc, and Merck & Co.etc. The market has high level of competition and remains the same during the forecasted period with constant pressure on players to launch new products.
Browse Full Information with Toc : http://www.briskinsights.com/report/contraceptive-market
Contact
Brisk Insights
Travis Bryant
+448081890034
www.briskinsights.com/
Office 1094
109 Vernon House
Friar Lane
Nottingham
NG1 6DQ
Travis Bryant
+448081890034
www.briskinsights.com/
Office 1094
109 Vernon House
Friar Lane
Nottingham
NG1 6DQ
Contact
Categories